The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

Can exhaustion cause hallucinations? Discover the surprising effects of sleep deprivation on the mind and body. From impaired ...

About 30 million people suffer from sleep apnea in the US, Troxel told Fox News Digital. The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly drug initially developed as a treatment for ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

It should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said in a news release.Obstructive sleep apnea, or OSA, affects as many as 30 million people in ...

It should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said in a news release.Obstructive sleep apnea, or OSA, affects as many as 30 million people in the U ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.